Skip to main content

and
  1. Article

    Open Access

    Author Correction: BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer

    Niki Karachaliou, Jordi Codony-Servat, Cristina Teixidó, Sara Pilotto in Scientific Reports (2023)

  2. Article

    Open Access

    BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer

    BIM is a proapoptotic protein that initiates apoptosis triggered by EGFR tyrosine kinase inhibitors (TKI). mTOR negatively regulates apoptosis and may influence response to EGFR TKI. We examined mRNA expressio...

    Niki Karachaliou, Jordi Codony-Servat, Cristina Teixidó, Sara Pilotto in Scientific Reports (2015)